NSG 533 Study Guide Exam III
, Module IX - Respiratory Disorders
Asthma - For the purpose of this course, consider only those 12 years of age or
older and adults
• Classification of medications, adverse effects, drug interactions, contraindications, monitoring
and patient counseling are always essential.
• Have you reviewed the learning objectives on the introductory page for each topic and those
found in the text?
• What are the major pathophysiological characteristics associated with asthma and how does
that relate to the therapeutic approach to disease?
• What are the precipitating factors and triggers associated with asthma?
February 2020 Seminars in Immunopathology 42(137)
o Recall discussion regarding ACEIs and beta-blockers (CV module).
• After a diagnosis is made, what factors are used to determine initial treatment, control
symptoms and minimize future risk of exacerbations (graphic provided in D2L and table 15-6, 15-
7)?
o Table 15-6: GINA Recommendations for Initial Treatment o Table 15-7: Gina Stepwise
Approach to Control Symptoms and Minimize Future Risk o Symptom presentation
Symptoms: night awakenings, need for SABA, work/school days missed, ability
to engage in normal activities
Lung function: spirometry, FEV and FEV 1/FVC (except for children 0-4 years)
o Exacerbations
A flare-up or exacerbation is an acute or sub-acute worsening of symptoms and
lung function compared with the patient’s usual status.
, Module IX - Respiratory Disorders
Asthma - For the purpose of this course, consider only those 12 years of age or
older and adults
• Classification of medications, adverse effects, drug interactions, contraindications, monitoring
and patient counseling are always essential.
• Have you reviewed the learning objectives on the introductory page for each topic and those
found in the text?
• What are the major pathophysiological characteristics associated with asthma and how does
that relate to the therapeutic approach to disease?
• What are the precipitating factors and triggers associated with asthma?
February 2020 Seminars in Immunopathology 42(137)
o Recall discussion regarding ACEIs and beta-blockers (CV module).
• After a diagnosis is made, what factors are used to determine initial treatment, control
symptoms and minimize future risk of exacerbations (graphic provided in D2L and table 15-6, 15-
7)?
o Table 15-6: GINA Recommendations for Initial Treatment o Table 15-7: Gina Stepwise
Approach to Control Symptoms and Minimize Future Risk o Symptom presentation
Symptoms: night awakenings, need for SABA, work/school days missed, ability
to engage in normal activities
Lung function: spirometry, FEV and FEV 1/FVC (except for children 0-4 years)
o Exacerbations
A flare-up or exacerbation is an acute or sub-acute worsening of symptoms and
lung function compared with the patient’s usual status.
